Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:9
  • full-text downloads in 30 days:8
article: 4 from 6  
Back back to result list
Medicinski časopis
2017, vol. 51, iss. 1, pp. 15-21
article language: Serbian
document type: Professional Paper
published on: 02/10/2017
doi: 10.5937/mckg51-13019
Multiresistant bacterial isolates in University Clinical Centre of the Republic of Srpska
University of Banja Luka, Faculty of Medicine, Republic of Srpska, B&H



Objective. The objective of this study was to determine the resistance and multi-drug resistance of clinical isolates on Surgical, Internal and Gynaecological clinic and Intensive Care Unit (ICU) at the University Clinical Center (UCC) of the Republic Srpska in the period from January to December 2015. Methods. To obtain relevant data on bacterial isolates and resistance the retrograde analysis of the laboratory documentation for the specified period of time was used. Statistical analysis was done by using the SPSS software package, along with the level of statistical significance of 5% (α=0.05). Results. There was a highly statistically significant difference in resistance of isolated bacteria to more classes of antibiotic between different species of bacteria and hospital wards (p<0.001). In the total sample of multi-drug resistant isolates (678) the most common isolated bacteria were Acinetobacter spp. (46.8%), followed by Pseudomonas spp. (16.4%), Klebsiella/Enterobacter spp. (14.2%), Escherichia coli (5.6%), Enterococcus spp. (4.9%), Staphylococcus aureus (4.4%), S. epidermidis (3.1%), and Serratia marcescens (1%). The largest number of multi-drug resistant bacteria were isolated at the ICU (p<0.001). Conclusion. There is a high prevalence of multidrug resistance Acinetobacter spp. in this study. The isolates from the ICU were more resistant than the isolates originating from Surgical, Internal and Gynaecological clinic.



Brkić, D.V., Stanko, A.P., Pleško, S., Tripković, V., Bedenić, B. (2015) Acinetobacter baumannii microbiological and phenotypic characteristics of isolates from Intensive Care Unit of the Department of Internal Medicine at the University Hospital Centre in Zagreb over a four-year period. Signa Vitae - A Journal In Intensive Care and Emergency Medicine, 10(Suppl 1): 13-15
Division of Public Health Services (2015) Recommendations for the prevention & control of MDRO and CDI for healthcare agencies and community settings. February. Dostupno na: (12.10.2016)
European Centre for Disease Prevention and Control Summary of the latest data on antibiotic resistance in the European Union. Dostupno na: (1. 3. 2017.)
European Centre for Disease Prevention and Control Carbapenem-resistant acinetobacter baumannii in healthcare settings. Dostupno na: (1. 3. 2017.)
Ghafur, A. (2014) Emergence of Pan-drug resistance amongst gram negative bacteria! The First case series from India. Journal of Microbiology and Infectious Diseases, 4(3): 86-91
Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., Jarlier, V., Voss, A., Pittet, D. (2013) Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control, 2(1): 31
Karageorgopoulos, D.E., Falagas, M.E. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infectious Diseases, 8(12): 751-762
Khalili, H., Izadpanah, M. (2015) Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. Journal of Research in Pharmacy Practice, 4(3): 105
Lee, C., Cho, I., Jeong, B., Lee, S. (2013) Strategies to Minimize Antibiotic Resistance. International Journal of Environmental Research and Public Health, 10(9): 4274-4305
Lisboa, T., Nagel, F. (2011) Infecção por patógenos multi-resistentes na UTI: como escapar?. Revista Brasileira de Terapia Intensiva, 23(2): 120-124
Magiorakos, A.-P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, J., Struelens, M.J., Vatopoulos, A., Weber, J.T., Monnet, D. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3): 268-281
Maragakis, L.L., Perl, T.M. (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clinical infectious diseases, 46(8): 1254-63
Maraki, S., Mantadakis, E., Mavromanolaki, V.E., Kofteridis, D.P., Samonis, G. (2016) A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital. Infection & Chemotherapy, 48(3): 190
Mitchell, B.G., Hall, L., MacBeth, D., Gardner, A., Halton, K. (2015) Hospital infection control units: Staffing, costs, and priorities. American Journal of Infection Control, 43(6): 612-616
Munoz-Price, L. S., Fajardo-Aquino, Y., Arheart, K.L., Cleary, T., DePascale, D., Pizano, L., Namias, N., Rivera, J.I., O’Hara, J.A., Doi, Y. (2013) Aerosolization of Acinetobacter baumannii in a Trauma ICU*. Critical Care Medicine, 41(8): 1915-1918
Nathan, C., Cars, O. (2014) Antibiotic Resistance - Problems, Progress, and Prospects. New England Journal of Medicine, 371(19): 1761-1763
Oliveira, V.D.C., Rubio, F.G., Almeida, M.T.G., Nogueira, M.C.L., Pignatari, A.C.C. (2015) Trends of 9,416 multidrug-resistant Gram-negative bacteria. Revista da Associação Médica Brasileira, 61(3): 244-249
Strausbaugh, L.J., Siegel, J.D., Weinstein, R.A. (2006) Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clinical infectious diseases, 42(6): 828-35
Tsioutis, C., Kritsotakis, E. I., Maraki, S., Gikas, A. (2010) Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients. European Journal of Clinical Microbiology & Infectious Diseases, 29(3): 301-305
U.S. Department of Health and Human Services-Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States. Dostupno na: (1.3. 2017)
Zilberberg, M.D., Shorr, A.F., Micek, S.T., Vazquez-Guillamet, C., Kollef, M.H. (2014) Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Critical Care, 18(6): 596